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Abstract
Background Polyetheretherketone (PEEK) and its com-
posites are polymers resistant to fatigue strain,
radiologically transparent, and have mechanical properties
suitable for a range of orthopaedic applications. In bulk
form, PEEK composites are generally accepted as bio-
compatible. In particulate form, however, the biologic
response relevant to joint replacement devices remains
unclear. The biologic response to wear particles affects the
longevity of total joint arthroplasties. Particles in the
phagocytozable size range of 0.1 lm to 10 lm are con-
sidered the most biologically reactive, particularly particles
with a mean size of\1 lm. This systematic review aimed
to identify the current evidence for the biologic response to
PEEK-based wear debris from total joint arthroplasties.
Questions/purposes (1) What are the quantitative char-
acteristics of PEEK-based wear particles produced by total
joint arthroplasties? (2) Do PEEK wear particles cause an
adverse biologic response when compared with UHMWPE
or a similar negative control biomaterial? (3) Is the bio-
logic response affected by particle characteristics?
Methods Embase and Ovid Medline databases were
searched for studies that quantified PEEK-based particle
characteristics and/or investigated the biologic response to
PEEK-based particles relevant to total joint arthroplasties.
The keyword search included brands of PEEK (eg,
MITCH, MOTIS) or variations of PEEK types and
nomenclature (eg, PAEK, CFR-PEEK) in combination
with types of joint (eg, hip, knee) and synonyms for wear
debris or immunologic response (eg, particles, cytotoxic-
ity). Peer-reviewed studies, published in English,
investigating total joint arthroplasty devices and cytotoxic
effects of PEEK particulates were included. Studies
investigating devices without articulating bearings (eg,
spinal instrumentation devices) and bulk material or con-
tact cytotoxicity were excluded. Of 129 studies, 15 were
selected for analysis and interpretation. No studies were
found that isolated and characterized PEEK wear particles
from retrieved periprosthetic human tissue samples.
Results In the four studies that quantified PEEK-based
particles produced using hip, knee, and spinal joint
replacement simulators, the mean particle size was 0.23 lm
to 2.0 lm. The absolute range reported was approximately
0.01 lm to 50 lm. Rod-like carbon particulates and
granular-shaped PEEK particles were identified in human
tissue by histologic analysis. Ten studies, including six
animal models (rat, mouse, and rabbit), three cell line
experiments, and two human tissue retreival studies,
investigated the biologic response to PEEK-based particles.
Qualitative histologic assessments showed immunologic
cell infiltration to be similar for PEEK particles when
compared with UHMWPE particles in all six of the animal
studies identified. However, increased inflammatory
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cytokine release (such as tumor necrosis factor-a) was
identified in only one in vitro study, but without substantial
suppression in macrophage viability. Only one study tested
the effects of particle size on cytotoxicity and found the
largest unfilled PEEK particles (approximately 13 lm) to
have a toxic effect; UHMWPE particles in the same size
range showed a similar cytotoxic effect.
Conclusions Wear particles produced by PEEK-based
bearings were, in almost all cases, in the phagocytozable
size range (0.1–10 lm). The studies that evaluated the
biologic response to PEEK-based particles generally found
cytotoxicity to be within acceptable limits relative to the
UHMWPE control, but inconsistent when inflammatory
cytokine release was considered.
Clinical Relevance To translate new and advanced
materials into clinical use more quickly, the clinical rele-
vance and validity of preclinical tests need to be improved.
To achieve this for PEEK-based devices, human tissue
retrieval studies including subsequent particle isolation and
characterization analyses are required. In vitro cell studies
using isolated wear particles from tissue or validated joint
replacement simulators, instead of manufactured particles,
are also required.
Introduction
Successful clinical performance of total joint arthroplasties
(TJAs) can be determined by many factors, including
material, biomechanical, and tribologic design considera-
tions. In particular, it has been established that wear and the
biologic reactivity of wear particles play a key role in long-
term implant survivorship [1]. Wear particles produced by
joint arthroplasty materials, in particular ultrahigh-molec-
ular-weight polyethylene (UHMWPE), have been
implicated in late aseptic loosening and subsequent joint
failure [8, 16, 18, 30, 37, 39]. Immunologic cells such as
macrophages phagocytoze the debris material, which ini-
tiates the release of inflammatory cytokines and stimulates
osteoclastic bone resorption [21]. Particle size, morphol-
ogy, volume, and composition are associated with biologic
reactivity [28]. The specific size and composition of par-
ticles most likely to be biologically reactive remain a
controversial topic, particularly among similar biomaterials
such as UHMWPE, highly crosslinked UHMWPE,
and vitamin E highly crosslinked UHWMPE [2, 10,
11, 20, 31, 32, 41, 42]. Particles in the phagocytozable size
range of 0.1 lm to 10 lm are considered the most bio-
logically reactive, particularly particles with a mean size of
\1 lm [7, 10, 11, 31, 32, 41]. Once particle size reduces
below approximately 50 nm, the biologic response dimin-
ishes [28]. A consensus around the role of particle volume
and/or dose has not been reached [10, 11, 22, 31, 38,
41, 45].
Polyetheretherketone (PEEK) and its carbon fiber com-
posites were introduced as bearing materials for TJAs in
the 1990s [46]. As a result of its resistance to fatigue strain,
radiologic transparency, and suitability for common ster-
ilization techniques, unfilled or neat PEEK has already
been widely used for spinal instrumentation [25]. Another
specific benefit of using PEEK and its composites is its
variable stiffness, usually facilitated by carbon fiber sup-
plementation [27]. This principle was demonstrated by the
development of carbon fiber-reinforced UHMWPE in the
1970s [40]. Carbon fiber-reinforced UHMWPE performed
well tribologically in the laboratory [40] but was less
successful in the clinic attributable, in part, to poor fatigue
resistance and carbon fiber release [33, 48]. In a similar
fashion, the mechanical properties of PEEK can be altered
by adding carbon fibers [43]. The elastic modulus of carbon
fiber-reinforced PEEK (CFR-PEEK) composites can be
tailored to mimic the properties of cortical bone (18 GPa)
or titanium alloy (110 GPa). Carbon fiber orientation and
length dictate these properties [43]. Perhaps, to mitigate a
repeat performance of carbon fiber-reinforced UHMWPE,
the implementation of clinically available PEEK-based
devices has been slow. Only one carbon fiber-reinforced
PEEK (CFR-PEEK) total hip arthroplasty (THA) (ABG II
Hip System; Stryker SA, Montreux, CH) [35, 36] and one
unfilled PEEK nucleus replacement device (NUBACTM;
Pioneer Surgical Technology, Marquette, MI, USA) [5] have
been evaluated clinically. However, currently no PEEK-
based TJA device has been cleared by the FDA for patient
use, although the use of PEEK for cervical disc replacement
[49] is under consideration. PEEK composites have shown
in vitro wear properties comparable to metal-on-metal
bearing couples [5, 38, 46] and are commonly used in trauma
implants and spinal fixation devices [25]. Although clinical
trials are the gold standard assessment for biologic response,
preclinical studies are a vital safeguard for patients and act as
a potential predictor of clinical performance. In bulk form,
PEEK composites generally are considered to be biocom-
patible [24, 47]. However, becausemany TJAs fail as a result
of biologic responses to particles, it is imperative to identify
whether or not the wear debris produced by PEEK devices is
cytotoxic or immunologically reactive.
This systematic review therefore aimed to answer the
following questions from preclinical and clinical studies:
(1) What are the quantitative characteristics of PEEK-
based wear particles produced by TJAs? (2) Do PEEK wear
particles cause an adverse biologic response when com-
pared with UHMWPE or a similar negative control
biomaterial? (3) Is the biologic response affected by par-
ticle characteristics?
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Search Strategy and Criteria
We searched Embase (1947 to October 1, 2015) and Ovid
MEDLINE (1946 to Week 1 of October 2015) for the
following syntax: (1) (PEEK-OPTIMA or MITCH-PCR or
MITCH or MOTIS or NUBAC).ti,ab; (2) (PEEK or PAEK
or polyetheretherketone or polyaryletheretherketone or
poly ether ether ketone or poly-ether-ether-ketone or poly
ether-ether ketone or CFR-PEEK or carbon-fiber reinforced
PEEK or carbon-fiber reinforced polyetheretherketone or
PEK or carbon nanotube-reinforced PEEK or CNF-PEEK
or CNF PEEK or all-PEEK).ti,ab; (3) (hip or knee or spine
or spinal or disc or finger or metacarpophalangeal or total
joint replacement or arthroplasty or joint replace-
ment$).ti,ab; (4) (particle$ or particulate$ or wear or debris
or bulk).ti,ab; (5) (osteoly$ or cytotoxic$ or immunologic
response or cytokine$ or macrophage$ or lymphocyte$ or
monocyte$ or RANK? or tumor necrosis factor or TNF$ or
interleukin or IL$ or $inflammatory).ti,ab; (6) (1) OR (2);
(7) (4) OR (5); and (8) (3) AND (6) AND (7).
The search was limited to peer-reviewed articles pub-
lished in English. We also searched Google Scholar,
reference lists, and conference proceedings using similar
terms. Both preclinical and clinical studies (including case
studies) were included providing quantitative descriptors of
particle characteristics. Articles not relevant to TJAs or
reporting biologic responses not relevant to PEEK-based
particles (such as contact cytotoxicity studies) were
excluded. Two researchers (AAS-P, KMP) reviewed all of
the studies independently. A third reviewer (CLB) clarified
conflicting decisions (Fig. 1). The initial search retrieved
216 studies, 129 of which were checked, and 14 relevant
studies were selected for interpretation and analysis. One
study included both a human tissue histology analysis and
an animal model.
A range of commercially available PEEK-based mate-
rials (Table 1) and custom-made variations were tested
across the included studies. There were no detailed char-
acterization studies of particles isolated from retrieved
periprosthetic human tissue samples.
Results
Four in vitro studies quantified the characteristics of PEEK-
based wear particles produced by TJAs, all of which gen-
erated particles in joint replacement simulators [5, 13–15]
(Table 2). Four different joint replacements were included.
Two types of total disc replacement were tested, one lumbar
and one cervical device; and two types of knee replacement
were assessed, a unicompartmental knee arthroplasty and a
total knee arthroplasty (TKA) designed for patients with
metal ion sensitivity. Six different bearing couples were
analyzed, two of which featured in more than one study.
Table 1. Commercially available PEEK-based materials and products used in the included studies
Material Commercial name Manufacturer Reference
Unfilled PEEK PEEK-Optima LT1 Invibio Ltd, Thornton-Cleveleys, UK [6]
[13]
[14]
CRF-PEEK (Pan) CFR-PEEK LT1 CA 30 Invibio Ltd [44]
[13]
[14]
CRF-PEEK (Pitch) ABG II Hip System
CFR-PEEK LT1 CP 30
Stryker SA, Montreux, CH
Invibio Ltd
[35]
[26]
[44]
CRF-PEEK (Pan) = PEEK containing 30% polyacrylonitrile based carbon fibers; CRF-PEEK (Pitch) = PEEK with a carbon fiber reinforcement
of 30% pitch fibers; PEEK = polyetheretherketone.
Fig. 1 Flow diagram shows the search strategy used. Asterisk
denotes studies that were included for more than one question.
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Feret’s diameter, the distance between two parallel planes
constraining each particle, was the most commonly reported
descriptor of particle size. The mean particle size (Feret’s
diameter) reported by the studies was 0.23 lm to 2.0 lm
with the absolute range of approximately 0.01 lm to 50 lm.
Self-mating unfilled PEEK bearings were tested for both
cervical and lumbar disc replacement devices. Lumbar disc
replacement devices produced larger particles than the
cervical disc devices using the same bearing materials.
CFR-PEEK (Pan)-on-cobalt chromium alloy bearings were
tested in both knee arthroplasty studies. The size and mor-
phology of particles were similar but the origin of particles
was different. For example, Grupp et al. [15] measured
particles from the primary articulation, whereas Grupp et al.
[13] analyzed debris from bushings and flanges used within
the TKA design.
Ten studies investigated the biologic response to PEEK-
based particles [6, 12, 17, 19, 23, 26, 29, 34, 35, 44]. Two
studies performed histologic analysis on retrieved human
tissue from failed THAs [26, 35] (Table 3). Evidence of
rod-like and granular particles phagocytozed by macro-
phages was reported but not attributed to wear debris-
induced failure. Six studies used in vivo animal models
(rat, mouse, and rabbit) to investigate responses to PEEK-
based particles [6, 12, 23, 26, 29, 44] (Table 4). All three
studies focusing on the spine identified a mild inflamma-
tory response that was local to the particles within the
epidural space. Using qualitative histologic descriptions,
the immunologic response was not different from the
UHMWPE particle groups with the number of studies
available [6, 12, 23]. Cunningham et al. [6] was the only
animal study to show a reduction in expression of inflam-
matory cytokines associated with unfilled PEEK particles
when compared with UHMWPE particles of the same size.
Two studies analyzed particles composed of two CFR-
PEEK composites, CFR-PEEK (Pitch) and CFR-PEEK
(Pan). (Pitch-based carbon fibers are produced using coal
tar pitch and pan-based carbon fibers use polyacrylonitrile
[Pan] as an initial processing material [9]. Pitch-based and
Pan-based composites exhibit different mechanical prop-
erties and can be tailored by the manufacturer [43].)
Depending on the cytokine (interleukin [IL]-1b, IL-6, or
tumor necrosis factor-a) and area investigated (bone mar-
row, synovium, or cartilage), the increase of cytokine
release cause by CFR-PEEK (Pitch) ranged between two-
and sevenfold when compared with the UHMWPE control
[29]. To a lesser and statistically significant extent, CFR-
PEEK (Pan) particles caused an increase in cytokine
expression in bone marrow tissue relative to UHMWPE
particles. This was the only study to report adverse tissue
reactions to PEEK-based particles when compared with
UHMWPE particles. Three studies used in vitro cell lines
to assess the biocompatibility of PEEK-based particlesT
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[17, 19, 34] (Table 5). Two studies found that PEEK-based
particles performed similarly to those of UHMWPE parti-
cles, ie, did not display evidence of cytotoxicity elicited by
the particles [19, 34]. Hallab et al. [17] reported a reduction
in both lactate dehydrogenase (LDH) activity and inflam-
matory cytokine release for PEEK particles relative to
UHMWPE particles, which suggested PEEK particles were
less biologically reactive than UHMWPE particles in this
study.
The in vitro study by Hallab et al. [17] was the only
study to associate particle characteristics with biologic
response. Unfilled PEEK particles, in the largest size range
(approximately 13 lm), reduced macrophage viability, but
by no more than 20% of the ‘‘medium only’’ control group
(ie, cells with no particles). In the same study, UHMWPE
particles, regardless of size, also caused cytotoxic effects.
No study directly compared unfilled PEEK against a CFR-
PEEK composite, which may reflect manufacturer appli-
cation preferences for each PEEK type. All of the
laboratory studies included in this review used commer-
cially purchased or processed particles that were produced
predominantly by cryomilling and/or cryopulverization.
Only five of the studies reported quantitative particle
characteristics for their biocompatibility testing, four of
which used particles produced by cryomilling or cryopul-
verization [6, 12, 17, 29, 44] (Table 6). Grupp et al. [12]
and Utzschneider et al. [44] artificially manufactured
particles to replicate their simulator-generated particles for
both size and morphology.
Discussion
Human tissue particle isolation studies are required to
definitively determine TJA wear particle characteristics. No
such study was identified and therefore in vivo particle
characteristics have not been confirmed or included in this
review. However, validated TJA wear simulation is an
accepted methodology used in the generation of wear debris
associated with specific TJAs. This review identified that
there is a lack of clinical studies focused on the wear par-
ticles produced by PEEK-based TJAs; therefore, wear
simulation and preclinical studies formed the majority of
studies used to answer the three main questions: (1) What
are the quantitative characteristics of PEEK-based wear
particles produced by TJAs? (2) Do PEEK wear particles
cause an adverse biologic response when compared with
UHMWPE or a similar negative control biomaterial? (3) Is
the biologic response affected by particle characteristics?
From the relatively small number of studies included, it was
found that wear debris produced by PEEK-based bearings
was within the phagocytozable size range (0.1–10 lm) and
exhibited comparable cytotoxic effects to UHMWPE par-
ticles despite a varied cytokine response across the studies.
Table 3. Human tissue retrieval studies after total joint arthroplasty failure
Study Joint Device Bearing
couple
Tissue type Analysis Outcomes
Latif et al.
[26]*
THA ABG II, Stryker
Orthopaedics,
Mahwah, NJ, USA
CFR-PEEK/
alumina
Synovium Histology Implantation time: not specified
Outcomes: visual inspection; histology (stain not
specified)
Results: tissue was gray/black but no synovial
hypertrophy; histology showed connective
tissue of varying density with dark material
present within; phagocytozed particles evident
within macrophages; rod-like particles and
smaller granular particles present; no
accumulation of lymphocytes or leucocytes
around blood vessels
Pace et al.
[35]*
THA ABG II, Stryker
Orthopaedics
CFR-PEEK/
alumina
Granulomatous
periprosthetic
tissue
Histology Implantation time: 26 months
Outcomes: histology (stain not specified)
Results: connective tissue of varying density
evident with areas of highly vascularized
granulation tissue; neutrophilic granulocyte,
lymphocyte, and plasma cell infiltration
evident; perivascular macrophages contained
small highly reflective metal particles, larger
black particles suggested to be carbon and
colorless granular particles exhibiting intense
birefringence thought to be of polymer origin
* Retrieved tissue from participants of the same clinical trial; CFR-PEEK = carbon fiber-reinforced polyetheretherketone.
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Several limitations were apparent as we surveyed the
available evidence. No studies to date have isolated and
characterized particles from retrieved human periprosthetic
tissue. Therefore, the true clinical relevance of particle size
and morphology distributions produced by simulators for
each joint remains unknown. Although Utzschneider et al.
[44] and Grupp et al. [12] replicated simulator-generated
particle size distributions and morphology accurately,
Table 4. In vivo animal model studies testing biocompatibility
Study Animal Model Test material UHMWPE
comparator?
Outcomes Relative
reactivity
Latif et al. [26] Rat Air pouch CFR-PEEK Yes* Test intervals: 1, 3, and 10 days; outcomes: visual
scoring system; pouch thickness; localization of
macrophages (ED1 antigen staining); vascular
proliferation (ICAM1 staining); results: visual
scoring system showed PE to cause more inflamed
than CFR-PEEK; no differences in pouch
thickness for all variables; no difference between
polyethylene and CRF-PEEK for ED1 staining or
ICAM1 staining
–
Kabir et al. [23] Rabbit Epidural PEK Yes Test intervals: 3 and 6 months; outcomes:
neurobehavioral observations (weekly);
inflammation identified via histology; results: no
neurological deficits or systemic toxicity;
crystalline wear debris identified and surrounded
by inflammatory cells; inflammation and
angiogenesis limited to periparticle epidural space
–
Utzschneider
et al. [44]
Mouse Knee CRF-PEEK (pitch)
CRF-PEEK (Pan)
Yes Test intervals: 1 week; outcomes: synovial
microcirculation assessment; fraction of rolling
leukocytes; histology (H&E); synovial membrane
thickness; results: no difference in functional
capillary density, fraction of rolling leukocytes,
nor the number of leukocytes adhered to the
endothelium between particle groups; no
differences in histological scoring for
inflammation or synovial membrane thickness
were identified between particle groups; the
control group had a significant reduction in each
of the aforementioned variables compared with
the particle groups
–
Cunningham
et al. [6]
Rabbit Epidural PEEK Yes Test intervals: 3 and 6 months; outcomes: histology
(H&E and HAM-56 staining); cytokine analysis
(ABC method; TNF-a, TNF-b, IL-1a, IL-1b, and
IL-6); results: PEEK exhibited a reduced cytokine
expression relative to UHMWPE
()
Lorber et al.
[29]
Mouse Knee CRF-PEEK (pitch)
CRF-PEEK (Pan)
Yes Test intervals: 1 week; outcomes: cytokine analysis
(ABC method; TNF-a, IL-1b, and IL-6); results:
CFR-PEEK (pitch) particles showed significantly
increased expression of: TNF-a, IL-1b, and IL-6
in articular cartilage and bone marrow, and TNF-
a in the synovial layer when compared with the
UHMWPE group; CFR-PEEK (Pan) particles
caused increased TNF-a and IL-1b levels in bone
marrow compared with UHMWPE particles
(+)
Grupp et al. [12] Rabbit Epidural CRF-PEEK Yes Test intervals: 3 and 6 months; outcomes: histology
(stain not specified); results: wear debris particles
surrounded by inflammatory cells were identified
in the vertebral canal; inflammation was limited to
the epidural space; CFR-PEEK showed a similar
histopathological reaction to UHMWPE particles
–
* Type of polyethylene not specified; related studies; (+) = increased reactivity; () = decreased reactivity; – = similar reactivity; reactivity was
judged relative to the within study UHMWPE control; CFR-PEEK = carbon fiber-reinforced polyetheretherketone; ICAM1 = intercellular
adhesion molecule 1; H&E = hematoxylin and eosin; TNF = tumor necrosis factor; IL = interleukin.
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particle production methods such as cryomilling or cry-
opulverization may not produce relevant particle surface
characteristics that are important for particle cell mem-
brane interactions for biologic response experiments. The
negative control in most studies consisted of UHMWPE
particles. PEEK is an alternative bearing material to more
modern UHMWPE formulations (such as highly cross-
linked UHMWPE and vitamin E infused or other
antioxidant-containing highly crosslinked UHMWPE) and
hard-on-hard bearings. Therefore, using conventional
UHMWPE particles as a control does not compare like for
like with the other commonly used alternatives to PEEK.
The biologic response identified in human histology studies
such as the investigation by Pace et al. [35] was con-
founded by particles produced from other interfaces of the
joint replacement device, eg, the fixation surface. Emula-
tion of in vivo conditions with in vitro experiments is a
challenge. Each study assessing cytotoxicity used different
cell lines and varying particle doses and volumes making
comparisons between studies inappropriate. Moreover,
current polymer isolation methods exploit material density
to separate wear debris particles from proteins (ie,
UHMWPE particles are buoyant in water, whereas proteins
sink). Human proteins and PEEK particles have similar
densities (approximately 1.3 g/cc), meaning a new particle
isolation method may be required to retrieve PEEK parti-
cles from tissue samples or simulator lubricant.
The mean particle size for PEEK-based material bearing
couples was within the 0.1-lm to 10-lm size range limit,
which is generally accepted as the most biologically
reactive. The absolute range reported was approximately
0.01 lm to 50 lm. Most devices produced particles in the
submicron size range, which was consistent with other
polymer articulations such as UHMWPE-on-cobalt chro-
mium alloy [14, 15]. However, these particle
characteristics were determined from only four simulator
studies and from devices that are not commonly implanted.
The two total disc replacements, one lumbar device and
one cervical device, both self-mating unfilled PEEK
implants, showed up to a 8.7 times difference in mean
particle diameter. The lumbar total disc replacement had
the largest mean particle size of the two disc replacement
types (2 lm), possibly as a result of different testing pro-
tocols (such as using higher loads and greater ROM)
relative to the cervical total disc replacement [3]. CFR-
PEEK (Pan)-on-cobalt chromium alloy was another bear-
ing couple investigated, although one joint was a
unicompartmental knee with a CFR-PEEK (Pan) primary
articulation. The other joint was a TKA developed for
patients with metal ion sensitivity and used CFR-PEEK
(Pan) for bushings and flanges. The wear particles pro-
duced by the two devices were similar in size and
morphology despite the method of articulation beingT
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substantially different. The similarity in particle charac-
teristics may indicate a common wear mode, although a
comprehensive damage mode assessment would be
required to draw such conclusions and is a recommenda-
tion for future studies. Unlike conventional THA and TKA
simulation, the clinical relevance of the particles produced
in simulator studies analyzing experimental joint replace-
ment devices and/or using novel biomaterials such as
PEEK needs to be validated against wear debris isolated
from retrieved human tissue samples. No human tissue
PEEK-based wear particle isolation studies were identified
within this review.
In vivo histopathologic analyses were the most prevalent
biocompatibility testing mode used for PEEK-based parti-
cles. Histology is a useful tool to retrospectively identify
the end condition of the tissue sample location. The two
human tissue sample retrieval studies were case studies,
each with a sample size of one. Although neither study
reported an immunologic response as the cause of failure,
generalizable conclusions based on these case studies
cannot be made. The animal studies included in this review
showed PEEK particles have a minimal effect on
immunologic cell recruitment, an indicator of immunologic
response, when compared with UHMWPE particles. A
similar immunologic response, identified using histology,
was reported for unfilled PEEK wear particles produced by
spinal instrumentation [39]. Despite the majority of the
animal studies showing a comparable biologic response
between particle groups, the range of different methods and
anatomic test locations means the results cannot be gen-
eralized with the limited literature available. The in vitro
cytotoxicity studies reported either no or low suppression
of macrophage viability and no substantial changes to LDH
activity or glutathione content. Different assays and cell
lines were used between studies, which limited relevant
comparisons. The clinical relevance of artificially manu-
factured particles used in animal studies requires further
investigation.
Particle size, morphology, volume (or dose), and com-
position are associated with biologic reactivity [29]. Hallab
et al. [17] was the only study included in this review to test
particle size effects on cytotoxicity. It is generally accepted
that particles in the phagocytozable size range (0.1–10 lm)
are the most biologically reactive [7, 10, 11, 31, 32, 41];
however, Hallab et al. [17] found the largest PEEK parti-
cles (approximately 13 lm) to have a cytotoxic effect.
However, in the same study, UHMWPE particles, regard-
less of size, also caused cytotoxic effects. These results
should be viewed with caution, because UHMWPE should
not have adverse effects on cell viability. This may be a
consequence of the particle manufacturing process. For
instance, cryomilling often uses a surfactant during the
milling process that can be degraded (eg, serum) or toxic to
cells (eg, oleic acid). The cytotoxicity observed for both the
UHMWPE and PEEK particles is therefore likely a con-
sequence of contamination. The clinical relevance of
PEEK particles in the [ 10-lm size range is yet to be
determined, although at least two of the simulator studies
identified by this review isolated and characterized parti-
cles in the[ 10-lm size range. Other factors to consider
when interpreting particle biocompatibility studies include
whether the particles produced by cryomilling/pulveriza-
tion differ in surface characteristics (eg, surface topography
and the presence of endotoxins) that could have an effect
on cell behavior. Additionally, a complex relationship
exists among particle size, debris volume, and tissue vol-
ume that has not been completely elucidated for UHMWPE
particles [10, 11, 22, 31, 38, 41, 45] let alone PEEK par-
ticles, which may provide additional factors to consider
independently of particle size and morphology such as
surface chemistry (eg, hydrophilicity) or the prescence of
carbon fiber particles and their characteristics.
Polyetheretherketone and its carbon composites are
polymers that have customizable mechanical properties
suitable for orthopaedic applications [43], high-performing
in vitro biotribologic properties [4], and are biocompatible
in bulk form [24, 47]. However, in light of CFR-
UHMWPE device failure in the decades before the
implementation of the current preclinical testing standards
[48], the biologic response to PEEK wear debris must be
investigated. From the published evidence included in this
review [5, 6, 12–15, 17, 19, 23, 26, 29, 34, 35, 44], wear
particles produced by PEEK-based bearings in TJA wear
simulators were, in almost all cases, in the phagocytozable
size range (0.1–10 lm). Despite this, the biologic response
to PEEK-based particles has thus far been generally found
not to cause cytotoxic effects, but was variable when
considering inflammatory cytokine release. It should be
noted that only 10 studies were identified in this review to
have investigated the biologic response to PEEK-based
particles from TJAs, all of which used model particles or
particles generated by cryomilling/cryopulverization.
Before preclinical assessments of biologic response can
accurately reflect the cell interactions with PEEK-based
particles, in vivo generated wear particle characteristics
must be determined. The first step to identifying clinically
relevant particle characteristics is to perform human tissue
retrieval studies with subsequent particle isolation and
characterization analyses. None have been completed for
PEEK-based TJA wear particles thus far. Once the wear
particle characteristics have been identified, the size and
morphologies can be emulated by joint replacement sim-
ulators, isolated, and immunologically tested in cell
studies. These steps are required before the biologic
response to PEEK-based particles can be determined
accurately and repeatably.
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